You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
UniQure
since
auto-detected in 5 stories
38 days ago
These are some of the stocks posting the largest moves midday.
UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency ⊕
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
4 months ago
FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease ⊕
UniQure needs to run another trial to prove its gene therapy "actually helps people with Huntington's disease," said a senior FDA official.
9 months ago
UniQure's therapy slows Huntington's disease progression in trial; Shares more than triple ○
UniQure's experimental gene therapy for Huntington's disease slowed progression of the brain disorder by 75% in an early-to-mid stage study, the company said.
Stocks making the biggest moves midday: Alibaba, Lithium Americas, Freeport-McMoRan, UniQure and more ○
These are the stocks posting the largest moves in midday trading.
page 1 of 1